Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eirik Ikdahl

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|September 19, 2025
Comment on: Risk of venous thromboembolism in people with rheumatoid arthritis: a population-based study in the UKEirik Ikdahl
RMD Open|March 1, 2024
Re-evaluating the mythical divide between traditional and novel cardiovascular risk factors in rheumatoid arthritisEirik Ikdahl, Mats Julius Stensrud
European Heart Journal. Cardiovascular Pharmacotherapy|June 26, 2026
Why Cardio-Rheumatology?Anne Grete Semb, Eirik Ikdahl, Anne Kerola
European Cardiology|January 28, 2025
Cardiovascular Implications of Non-steroidal Anti-inflammatory Drugs: A Comprehensive Review, with Emphasis on Patients with Rheumatoid ArthritisEirik Ikdahl, Anne Kerola, Eli Sollerud, et al.
Annals of the Rheumatic Diseases|April 23, 2024
No sign of elevated cardiovascular risk in patients with seropositive rheumatoid arthritis who remain on stable antirheumatic therapy: results from the nationwide Norwegian Cardio-Rheuma RegisterEirik Ikdahl, Anne Grete Semb, Anne M Kerola
Rheumatology (Oxford, England)|February 10, 2016
Chronic kidney disease reduces risk of cardiovascular disease in patients with rheumatoid arthritis according to the QRISK lifetime cardiovascular risk calculatorEirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe, et al.
Journal of Clinical Lipidology|March 7, 2025
Assessment of lipid-lowering therapies in high-risk patients with inflammatory joint diseases-Insights from a preventive cardio-rheuma clinicEli P Sollerud, Eirik Ikdahl, Anne Kerola, et al.
Nature Reviews. Rheumatology|June 5, 2020
Atherosclerotic cardiovascular disease prevention in rheumatoid arthritisAnne Grete Semb, Eirik Ikdahl, Grunde Wibetoe, et al.
Rheumatology (Oxford, England)|August 22, 2024
Rheumatoid arthritis and the risk of ischaemic stroke after diagnosis of atrial fibrillation: a Norwegian nationwide register studyAnne M Kerola, Eirik Ikdahl, Ingrid Engebretsen, et al.
Seminars in Arthritis and Rheumatism|October 17, 2025
Reply to Dziewierz and to Zhang and YangEirik Ikdahl, Anne Kerola, Peder L Myhre, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|September 19, 2025
Comment on: Risk of venous thromboembolism in people with rheumatoid arthritis: a population-based study in the UKEirik Ikdahl
RMD Open|March 1, 2024
Re-evaluating the mythical divide between traditional and novel cardiovascular risk factors in rheumatoid arthritisEirik Ikdahl, Mats Julius Stensrud
European Heart Journal. Cardiovascular Pharmacotherapy|June 26, 2026
Why Cardio-Rheumatology?Anne Grete Semb, Eirik Ikdahl, Anne Kerola
European Cardiology|January 28, 2025
Cardiovascular Implications of Non-steroidal Anti-inflammatory Drugs: A Comprehensive Review, with Emphasis on Patients with Rheumatoid ArthritisEirik Ikdahl, Anne Kerola, Eli Sollerud, et al.
Annals of the Rheumatic Diseases|April 23, 2024
No sign of elevated cardiovascular risk in patients with seropositive rheumatoid arthritis who remain on stable antirheumatic therapy: results from the nationwide Norwegian Cardio-Rheuma RegisterEirik Ikdahl, Anne Grete Semb, Anne M Kerola
Rheumatology (Oxford, England)|February 10, 2016
Chronic kidney disease reduces risk of cardiovascular disease in patients with rheumatoid arthritis according to the QRISK lifetime cardiovascular risk calculatorEirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe, et al.
Journal of Clinical Lipidology|March 7, 2025
Assessment of lipid-lowering therapies in high-risk patients with inflammatory joint diseases-Insights from a preventive cardio-rheuma clinicEli P Sollerud, Eirik Ikdahl, Anne Kerola, et al.
Nature Reviews. Rheumatology|June 5, 2020
Atherosclerotic cardiovascular disease prevention in rheumatoid arthritisAnne Grete Semb, Eirik Ikdahl, Grunde Wibetoe, et al.
Rheumatology (Oxford, England)|August 22, 2024
Rheumatoid arthritis and the risk of ischaemic stroke after diagnosis of atrial fibrillation: a Norwegian nationwide register studyAnne M Kerola, Eirik Ikdahl, Ingrid Engebretsen, et al.
Seminars in Arthritis and Rheumatism|October 17, 2025
Reply to Dziewierz and to Zhang and YangEirik Ikdahl, Anne Kerola, Peder L Myhre, et al.
Pageof 4